#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Medicinal Sesquiterpenes
1-1	0-2	4.	_	_	_	_
1-2	3-12	Medicinal	substance[1]	new[1]	coref	9-6[65_1]
1-3	13-27	Sesquiterpenes	substance[1]	new[1]	_	_

#Text=Sesquiterpene biosynthesis normally begins in the cytosol via the C15 prenyl diphosphate FDP , which itself is derived from mevalonic acid and the MVA pathway .
2-1	28-41	Sesquiterpene	substance[2]	new[2]	_	_
2-2	42-54	biosynthesis	substance[2]	new[2]	_	_
2-3	55-63	normally	_	_	_	_
2-4	64-70	begins	_	_	_	_
2-5	71-73	in	_	_	_	_
2-6	74-77	the	place[3]	new[3]	_	_
2-7	78-85	cytosol	place[3]	new[3]	_	_
2-8	86-89	via	place[3]	new[3]	_	_
2-9	90-93	the	place[3]|abstract[7]	new[3]|new[7]	ana	2-16[0_7]
2-10	94-97	C15	place[3]|time|abstract[7]	new[3]|new|new[7]	_	_
2-11	98-104	prenyl	place[3]|abstract|abstract[7]	new[3]|new|new[7]	_	_
2-12	105-116	diphosphate	place[3]|person|abstract[7]	new[3]|new|new[7]	_	_
2-13	117-120	FDP	place[3]|abstract[7]	new[3]|new[7]	_	_
2-14	121-122	,	_	_	_	_
2-15	123-128	which	_	_	_	_
2-16	129-135	itself	abstract	giv	coref	3-5
2-17	136-138	is	_	_	_	_
2-18	139-146	derived	_	_	_	_
2-19	147-151	from	_	_	_	_
2-20	152-161	mevalonic	abstract|substance[10]	new|new[10]	_	_
2-21	162-166	acid	substance[10]	new[10]	_	_
2-22	167-170	and	_	_	_	_
2-23	171-174	the	abstract[12]	new[12]	_	_
2-24	175-178	MVA	abstract|abstract[12]	new|new[12]	_	_
2-25	179-186	pathway	abstract[12]	new[12]	_	_
2-26	187-188	.	_	_	_	_

#Text=Sesquiterpene synthases act on FDP to yield hundreds of sesquiterpene hydrocarbons and alcohols based on dozens of carbon skeletons .
3-1	189-202	Sesquiterpene	substance[13]	new[13]	_	_
3-2	203-212	synthases	substance[13]	new[13]	_	_
3-3	213-216	act	_	_	_	_
3-4	217-219	on	_	_	_	_
3-5	220-223	FDP	abstract	giv	coref	25-8
3-6	224-226	to	_	_	_	_
3-7	227-232	yield	_	_	_	_
3-8	233-241	hundreds	substance[15]	new[15]	coref	5-13[40_15]
3-9	242-244	of	substance[15]	new[15]	_	_
3-10	245-258	sesquiterpene	substance[15]	new[15]	_	_
3-11	259-271	hydrocarbons	substance[15]	new[15]	_	_
3-12	272-275	and	_	_	_	_
3-13	276-284	alcohols	substance	new	_	_
3-14	285-290	based	_	_	_	_
3-15	291-293	on	_	_	_	_
3-16	294-300	dozens	abstract[18]	new[18]	ana	4-1[0_18]
3-17	301-303	of	abstract[18]	new[18]	_	_
3-18	304-310	carbon	substance|abstract[18]	new|new[18]	coref	20-15
3-19	311-320	skeletons	abstract[18]	new[18]	_	_
3-20	321-322	.	_	_	_	_

#Text=They are frequently responsible for familiar scents and flavors , for instance ginger ( gingerol ) , clove , cannabis , rosemary ( β-caryophyllene ) , patchouli ( patchoulol ) , sandalwood ( α-santalene ) , and rain ( geosmin , a bacterial sesquiterpene ) .
4-1	323-327	They	abstract	giv	_	_
4-2	328-331	are	_	_	_	_
4-3	332-342	frequently	_	_	_	_
4-4	343-354	responsible	_	_	_	_
4-5	355-358	for	_	_	_	_
4-6	359-367	familiar	abstract[20]	new[20]	_	_
4-7	368-374	scents	abstract[20]	new[20]	_	_
4-8	375-378	and	_	_	_	_
4-9	379-386	flavors	abstract[21]	new[21]	_	_
4-10	387-388	,	abstract[21]	new[21]	_	_
4-11	389-392	for	abstract[21]	new[21]	_	_
4-12	393-401	instance	abstract[21]|plant[22]	new[21]|new[22]	appos	4-15[0_22]
4-13	402-408	ginger	abstract[21]|plant[22]	new[21]|new[22]	_	_
4-14	409-410	(	_	_	_	_
4-15	411-419	gingerol	plant	giv	_	_
4-16	420-421	)	_	_	_	_
4-17	422-423	,	_	_	_	_
4-18	424-429	clove	plant	new	_	_
4-19	430-431	,	_	_	_	_
4-20	432-440	cannabis	plant	new	_	_
4-21	441-442	,	_	_	_	_
4-22	443-451	rosemary	person	new	_	_
4-23	452-453	(	_	_	_	_
4-24	454-469	β-caryophyllene	substance	new	_	_
4-25	470-471	)	_	_	_	_
4-26	472-473	,	_	_	_	_
4-27	474-483	patchouli	substance	new	_	_
4-28	484-485	(	_	_	_	_
4-29	486-496	patchoulol	object	new	_	_
4-30	497-498	)	_	_	_	_
4-31	499-500	,	_	_	_	_
4-32	501-511	sandalwood	substance	new	appos	4-34
4-33	512-513	(	_	_	_	_
4-34	514-525	α-santalene	substance	giv	_	_
4-35	526-527	)	_	_	_	_
4-36	528-529	,	_	_	_	_
4-37	530-533	and	_	_	_	_
4-38	534-538	rain	substance	new	_	_
4-39	539-540	(	_	_	_	_
4-40	541-548	geosmin	substance|substance[34]	new|new[34]	ana	5-1[0_34]
4-41	549-550	,	substance[34]	new[34]	_	_
4-42	551-552	a	substance[34]|substance[36]	new[34]|new[36]	_	_
4-43	553-562	bacterial	substance[34]|substance|substance[36]	new[34]|new|new[36]	_	_
4-44	563-576	sesquiterpene	substance[34]|substance[36]	new[34]|new[36]	_	_
4-45	577-578	)	_	_	_	_
4-46	579-580	.	_	_	_	_

#Text=They are the heaviest of the volatile terpenes under standard conditions ( diterpene hydrocarbons ordinarily require heating to form gases ) .
5-1	581-585	They	substance	giv	_	_
5-2	586-589	are	_	_	_	_
5-3	590-593	the	_	_	_	_
5-4	594-602	heaviest	_	_	_	_
5-5	603-605	of	_	_	_	_
5-6	606-609	the	substance[38]	new[38]	_	_
5-7	610-618	volatile	substance[38]	new[38]	_	_
5-8	619-627	terpenes	substance[38]	new[38]	_	_
5-9	628-633	under	substance[38]	new[38]	_	_
5-10	634-642	standard	substance[38]|abstract[39]	new[38]|new[39]	_	_
5-11	643-653	conditions	substance[38]|abstract[39]	new[38]|new[39]	_	_
5-12	654-655	(	_	_	_	_
5-13	656-665	diterpene	substance[40]	giv[40]	_	_
5-14	666-678	hydrocarbons	substance[40]	giv[40]	_	_
5-15	679-689	ordinarily	_	_	_	_
5-16	690-697	require	_	_	_	_
5-17	698-705	heating	_	_	_	_
5-18	706-708	to	_	_	_	_
5-19	709-713	form	event	new	none|none	5-19[0_200]|20-14
5-20	714-719	gases	substance	new	_	_
5-21	720-721	)	_	_	_	_
5-22	722-723	.	_	_	_	_

#Text=Plant families known to be principal producers of sesquiterpene volatiles include the Lamiaceae , Geraniaceae , Rutaceae , Myrtaceae , Cannabaceae , and Gingeraceae .
6-1	724-729	Plant	person|abstract[43]	new|new[43]	_	_
6-2	730-738	families	abstract[43]	new[43]	_	_
6-3	739-744	known	_	_	_	_
6-4	745-747	to	_	_	_	_
6-5	748-750	be	_	_	_	_
6-6	751-760	principal	person[44]	new[44]	_	_
6-7	761-770	producers	person[44]	new[44]	_	_
6-8	771-773	of	person[44]	new[44]	_	_
6-9	774-787	sesquiterpene	person[44]|substance[45]	new[44]|new[45]	_	_
6-10	788-797	volatiles	person[44]|substance[45]	new[44]|new[45]	_	_
6-11	798-805	include	_	_	_	_
6-12	806-809	the	plant[46]	new[46]	_	_
6-13	810-819	Lamiaceae	plant[46]	new[46]	_	_
6-14	820-821	,	_	_	_	_
6-15	822-833	Geraniaceae	animal	new	_	_
6-16	834-835	,	_	_	_	_
6-17	836-844	Rutaceae	animal	new	_	_
6-18	845-846	,	_	_	_	_
6-19	847-856	Myrtaceae	animal	new	_	_
6-20	857-858	,	_	_	_	_
6-21	859-870	Cannabaceae	plant	new	_	_
6-22	871-872	,	_	_	_	_
6-23	873-876	and	_	_	_	_
6-24	877-888	Gingeraceae	plant	new	_	_
6-25	889-890	.	_	_	_	_

#Text=The use of these essential oils in traditional herbal medicine such as aromatherapy and Ayurvedic medicine is well documented .
7-1	891-894	The	abstract[52]	new[52]	coref	8-6[59_52]
7-2	895-898	use	abstract[52]	new[52]	_	_
7-3	899-901	of	abstract[52]	new[52]	_	_
7-4	902-907	these	abstract[52]|substance[53]	new[52]|new[53]	ana	8-6[0_53]
7-5	908-917	essential	abstract[52]|substance[53]	new[52]|new[53]	_	_
7-6	918-922	oils	abstract[52]|substance[53]	new[52]|new[53]	_	_
7-7	923-925	in	abstract[52]|substance[53]	new[52]|new[53]	_	_
7-8	926-937	traditional	abstract[52]|substance[53]|abstract[54]	new[52]|new[53]|new[54]	_	_
7-9	938-944	herbal	abstract[52]|substance[53]|abstract[54]	new[52]|new[53]|new[54]	_	_
7-10	945-953	medicine	abstract[52]|substance[53]|abstract[54]	new[52]|new[53]|new[54]	_	_
7-11	954-958	such	abstract[52]|substance[53]|abstract[54]	new[52]|new[53]|new[54]	_	_
7-12	959-961	as	abstract[52]|substance[53]|abstract[54]	new[52]|new[53]|new[54]	_	_
7-13	962-974	aromatherapy	abstract[52]|substance[53]|abstract[54]|substance	new[52]|new[53]|new[54]|new	_	_
7-14	975-978	and	abstract[52]|substance[53]|abstract[54]	new[52]|new[53]|new[54]	_	_
7-15	979-988	Ayurvedic	abstract[52]|substance[53]|abstract[54]|abstract[56]	new[52]|new[53]|new[54]|new[56]	coref	14-15[89_56]
7-16	989-997	medicine	abstract[52]|substance[53]|abstract[54]|abstract[56]	new[52]|new[53]|new[54]|new[56]	_	_
7-17	998-1000	is	_	_	_	_
7-18	1001-1005	well	_	_	_	_
7-19	1006-1016	documented	_	_	_	_
7-20	1017-1018	.	_	_	_	_

#Text=There is currently little evidence their use confers actual medical benefits , yet their use remains widespread due to their aesthetic , historical , and cultural significance .
8-1	1019-1024	There	_	_	_	_
8-2	1025-1027	is	_	_	_	_
8-3	1028-1037	currently	abstract[57]	new[57]	_	_
8-4	1038-1044	little	abstract[57]	new[57]	_	_
8-5	1045-1053	evidence	abstract[57]	new[57]	_	_
8-6	1054-1059	their	substance|abstract[59]	giv|giv[59]	ana|coref	8-14|8-14[62_59]
8-7	1060-1063	use	abstract[59]	giv[59]	_	_
8-8	1064-1071	confers	_	_	_	_
8-9	1072-1078	actual	abstract[60]	new[60]	_	_
8-10	1079-1086	medical	abstract[60]	new[60]	_	_
8-11	1087-1095	benefits	abstract[60]	new[60]	_	_
8-12	1096-1097	,	_	_	_	_
8-13	1098-1101	yet	_	_	_	_
8-14	1102-1107	their	substance|abstract[62]	giv|giv[62]	ana	8-20
8-15	1108-1111	use	abstract[62]	giv[62]	_	_
8-16	1112-1119	remains	_	_	_	_
8-17	1120-1130	widespread	_	_	_	_
8-18	1131-1134	due	_	_	_	_
8-19	1135-1137	to	_	_	_	_
8-20	1138-1143	their	substance|abstract[64]	giv|new[64]	_	_
8-21	1144-1153	aesthetic	abstract[64]	new[64]	_	_
8-22	1154-1155	,	abstract[64]	new[64]	_	_
8-23	1156-1166	historical	abstract[64]	new[64]	_	_
8-24	1167-1168	,	abstract[64]	new[64]	_	_
8-25	1169-1172	and	abstract[64]	new[64]	_	_
8-26	1173-1181	cultural	abstract[64]	new[64]	_	_
8-27	1182-1194	significance	abstract[64]	new[64]	_	_
8-28	1195-1196	.	_	_	_	_

#Text=On the other hand , a number of highly functionalized , non-volatile sesquiterpenes of plant origin have demonstrated highly specific biological activity and have therefore been investigated for their clinical potential .
9-1	1197-1199	On	_	_	_	_
9-2	1200-1203	the	_	_	_	_
9-3	1204-1209	other	_	_	_	_
9-4	1210-1214	hand	_	_	_	_
9-5	1215-1216	,	_	_	_	_
9-6	1217-1218	a	substance[65]	giv[65]	ana	9-29[0_65]
9-7	1219-1225	number	substance[65]	giv[65]	_	_
9-8	1226-1228	of	substance[65]	giv[65]	_	_
9-9	1229-1235	highly	substance[65]	giv[65]	_	_
9-10	1236-1250	functionalized	substance[65]	giv[65]	_	_
9-11	1251-1252	,	substance[65]	giv[65]	_	_
9-12	1253-1265	non-volatile	substance[65]	giv[65]	_	_
9-13	1266-1280	sesquiterpenes	substance[65]	giv[65]	_	_
9-14	1281-1283	of	substance[65]	giv[65]	_	_
9-15	1284-1289	plant	substance[65]|plant|abstract[67]	giv[65]|new|new[67]	coref	10-7
9-16	1290-1296	origin	substance[65]|abstract[67]	giv[65]|new[67]	_	_
9-17	1297-1301	have	_	_	_	_
9-18	1302-1314	demonstrated	_	_	_	_
9-19	1315-1321	highly	abstract[68]	new[68]	_	_
9-20	1322-1330	specific	abstract[68]	new[68]	_	_
9-21	1331-1341	biological	abstract[68]	new[68]	_	_
9-22	1342-1350	activity	abstract[68]	new[68]	_	_
9-23	1351-1354	and	_	_	_	_
9-24	1355-1359	have	_	_	_	_
9-25	1360-1369	therefore	_	_	_	_
9-26	1370-1374	been	_	_	_	_
9-27	1375-1387	investigated	_	_	_	_
9-28	1388-1391	for	_	_	_	_
9-29	1392-1397	their	substance|abstract[70]	giv|new[70]	_	_
9-30	1398-1406	clinical	abstract[70]	new[70]	_	_
9-31	1407-1416	potential	abstract[70]	new[70]	_	_
9-32	1417-1418	.	_	_	_	_

#Text=A selection of these medically useful plant sesquiterpenoids follows .
10-1	1419-1420	A	abstract[71]	new[71]	_	_
10-2	1421-1430	selection	abstract[71]	new[71]	_	_
10-3	1431-1433	of	abstract[71]	new[71]	_	_
10-4	1434-1439	these	abstract[71]|substance[73]	new[71]|new[73]	_	_
10-5	1440-1449	medically	abstract[71]|substance[73]	new[71]|new[73]	_	_
10-6	1450-1456	useful	abstract[71]|substance[73]	new[71]|new[73]	_	_
10-7	1457-1462	plant	abstract[71]|plant|substance[73]	new[71]|giv|new[73]	coref	28-7
10-8	1463-1479	sesquiterpenoids	abstract[71]|substance[73]	new[71]|new[73]	_	_
10-9	1480-1487	follows	_	_	_	_
10-10	1488-1489	.	_	_	_	_

#Text=4.1 .
11-1	1490-1493	4.1	abstract	new	_	_
11-2	1494-1495	.	_	_	_	_

#Text=Artemisinin
12-1	1496-1507	Artemisinin	person	new	coref	13-21[82_0]

#Text=Wormwood ( Artemisia annua L. , or qinghaosu , Asteraceae ) is native to China and is the source of the sesquiterpene endoperoxide artemisinin , shown to be highly effective at treating malaria .
13-1	1508-1516	Wormwood	person	new	_	_
13-2	1517-1518	(	_	_	_	_
13-3	1519-1528	Artemisia	_	_	_	_
13-4	1529-1534	annua	_	_	_	_
13-5	1535-1537	L.	_	_	_	_
13-6	1538-1539	,	_	_	_	_
13-7	1540-1542	or	_	_	_	_
13-8	1543-1552	qinghaosu	plant	new	appos	13-10
13-9	1553-1554	,	_	_	_	_
13-10	1555-1565	Asteraceae	plant	giv	coref	14-24[92_0]
13-11	1566-1567	)	_	_	_	_
13-12	1568-1570	is	_	_	_	_
13-13	1571-1577	native	_	_	_	_
13-14	1578-1580	to	_	_	_	_
13-15	1581-1586	China	place	new	_	_
13-16	1587-1590	and	_	_	_	_
13-17	1591-1593	is	_	_	_	_
13-18	1594-1597	the	abstract[80]	new[80]	_	_
13-19	1598-1604	source	abstract[80]	new[80]	_	_
13-20	1605-1607	of	abstract[80]	new[80]	_	_
13-21	1608-1611	the	abstract[80]|person[82]	new[80]|giv[82]	coref	16-1[0_82]
13-22	1612-1625	sesquiterpene	abstract[80]|person[82]	new[80]|giv[82]	_	_
13-23	1626-1638	endoperoxide	abstract[80]|substance|person[82]	new[80]|new|giv[82]	coref	16-9
13-24	1639-1650	artemisinin	abstract[80]|person[82]	new[80]|giv[82]	_	_
13-25	1651-1652	,	_	_	_	_
13-26	1653-1658	shown	_	_	_	_
13-27	1659-1661	to	_	_	_	_
13-28	1662-1664	be	_	_	_	_
13-29	1665-1671	highly	_	_	_	_
13-30	1672-1681	effective	_	_	_	_
13-31	1682-1684	at	_	_	_	_
13-32	1685-1693	treating	_	_	_	_
13-33	1694-1701	malaria	abstract	new	coref	14-39
13-34	1702-1703	.	_	_	_	_

#Text=In the early 1970s , phytochemists such as Youyou Tu investigated plants used in traditional Chinese herbal medicine and identified the usefulness of the traditional remedy qinghaosu in eradicating Plasmodium spp . infections , the causative agent of malaria , for which she received a Nobel Prize in Medicine in 2015 .
14-1	1704-1706	In	_	_	_	_
14-2	1707-1710	the	time[84]	new[84]	_	_
14-3	1711-1716	early	time[84]	new[84]	_	_
14-4	1717-1722	1970s	time[84]	new[84]	_	_
14-5	1723-1724	,	_	_	_	_
14-6	1725-1738	phytochemists	person[85]	new[85]	_	_
14-7	1739-1743	such	person[85]	new[85]	_	_
14-8	1744-1746	as	person[85]	new[85]	_	_
14-9	1747-1753	Youyou	person[85]|person[86]	new[85]|new[86]	_	_
14-10	1754-1756	Tu	person[85]|person[86]	new[85]|new[86]	_	_
14-11	1757-1769	investigated	_	_	_	_
14-12	1770-1776	plants	plant	new	coref	24-20
14-13	1777-1781	used	_	_	_	_
14-14	1782-1784	in	_	_	_	_
14-15	1785-1796	traditional	abstract[89]	giv[89]	coref	14-49[0_89]
14-16	1797-1804	Chinese	abstract[89]	giv[89]	_	_
14-17	1805-1811	herbal	abstract|abstract[89]	new|giv[89]	_	_
14-18	1812-1820	medicine	abstract[89]	giv[89]	_	_
14-19	1821-1824	and	_	_	_	_
14-20	1825-1835	identified	_	_	_	_
14-21	1836-1839	the	abstract[90]	new[90]	_	_
14-22	1840-1850	usefulness	abstract[90]	new[90]	_	_
14-23	1851-1853	of	abstract[90]	new[90]	_	_
14-24	1854-1857	the	abstract[90]|plant[92]	new[90]|giv[92]	_	_
14-25	1858-1869	traditional	abstract[90]|plant[92]	new[90]|giv[92]	_	_
14-26	1870-1876	remedy	abstract[90]|substance|plant[92]	new[90]|new|giv[92]	_	_
14-27	1877-1886	qinghaosu	abstract[90]|plant[92]	new[90]|giv[92]	_	_
14-28	1887-1889	in	_	_	_	_
14-29	1890-1901	eradicating	_	_	_	_
14-30	1902-1912	Plasmodium	substance	new	coref	21-13
14-31	1913-1916	spp	_	_	_	_
14-32	1917-1918	.	_	_	_	_
14-33	1919-1929	infections	abstract	new	_	_
14-34	1930-1931	,	_	_	_	_
14-35	1932-1935	the	person[95]	new[95]	ana	14-43[0_95]
14-36	1936-1945	causative	person[95]	new[95]	_	_
14-37	1946-1951	agent	person[95]	new[95]	_	_
14-38	1952-1954	of	person[95]	new[95]	_	_
14-39	1955-1962	malaria	person[95]|abstract	new[95]|giv	_	_
14-40	1963-1964	,	_	_	_	_
14-41	1965-1968	for	_	_	_	_
14-42	1969-1974	which	_	_	_	_
14-43	1975-1978	she	person	giv	_	_
14-44	1979-1987	received	_	_	_	_
14-45	1988-1989	a	abstract[98]	new[98]	_	_
14-46	1990-1995	Nobel	abstract[98]	new[98]	_	_
14-47	1996-2001	Prize	abstract[98]	new[98]	_	_
14-48	2002-2004	in	_	_	_	_
14-49	2005-2013	Medicine	abstract	giv	ana	15-1
14-50	2014-2016	in	_	_	_	_
14-51	2017-2021	2015	time	new	_	_
14-52	2022-2023	.	_	_	_	_

#Text=It is more effective against a broader range of life cycle stages of the apicomplexan parasite than traditional anti-malarials such as quinine .
15-1	2024-2026	It	abstract	giv	_	_
15-2	2027-2029	is	_	_	_	_
15-3	2030-2034	more	_	_	_	_
15-4	2035-2044	effective	_	_	_	_
15-5	2045-2052	against	_	_	_	_
15-6	2053-2054	a	abstract[102]	new[102]	_	_
15-7	2055-2062	broader	abstract[102]	new[102]	_	_
15-8	2063-2068	range	abstract[102]	new[102]	_	_
15-9	2069-2071	of	abstract[102]	new[102]	_	_
15-10	2072-2076	life	abstract[102]|abstract|abstract[105]	new[102]|new|new[105]	coref	23-28[149_105]
15-11	2077-2082	cycle	abstract[102]|abstract|abstract[105]	new[102]|new|new[105]	_	_
15-12	2083-2089	stages	abstract[102]|abstract[105]	new[102]|new[105]	_	_
15-13	2090-2092	of	abstract[102]|abstract[105]	new[102]|new[105]	_	_
15-14	2093-2096	the	abstract[102]|abstract[105]|person[106]	new[102]|new[105]|new[106]	coref	22-7[135_0]
15-15	2097-2109	apicomplexan	abstract[102]|abstract[105]|person[106]	new[102]|new[105]|new[106]	_	_
15-16	2110-2118	parasite	abstract[102]|abstract[105]|person[106]	new[102]|new[105]|new[106]	_	_
15-17	2119-2123	than	abstract[102]|abstract[105]|person[106]	new[102]|new[105]|new[106]	_	_
15-18	2124-2135	traditional	abstract[102]|abstract[105]|person[106]|substance[107]	new[102]|new[105]|new[106]|new[107]	_	_
15-19	2136-2150	anti-malarials	abstract[102]|abstract[105]|person[106]|substance[107]	new[102]|new[105]|new[106]|new[107]	_	_
15-20	2151-2155	such	abstract[102]|abstract[105]|person[106]|substance[107]	new[102]|new[105]|new[106]|new[107]	_	_
15-21	2156-2158	as	abstract[102]|abstract[105]|person[106]|substance[107]	new[102]|new[105]|new[106]|new[107]	_	_
15-22	2159-2166	quinine	abstract[102]|abstract[105]|person[106]|substance[107]|substance	new[102]|new[105]|new[106]|new[107]|new	_	_
15-23	2167-2168	.	_	_	_	_

#Text=Artemisinin is a sesquiterpene lactone with an unusual endoperoxide ring which imparts its anti-malarial properties (
16-1	2169-2180	Artemisinin	substance	giv	coref	16-3[110_0]
16-2	2181-2183	is	_	_	_	_
16-3	2184-2185	a	substance[110]	giv[110]	ana	16-13[0_110]
16-4	2186-2199	sesquiterpene	substance[110]	giv[110]	_	_
16-5	2200-2207	lactone	substance[110]	giv[110]	_	_
16-6	2208-2212	with	substance[110]	giv[110]	_	_
16-7	2213-2215	an	substance[110]|object[112]	giv[110]|new[112]	coref	31-13[202_112]
16-8	2216-2223	unusual	substance[110]|object[112]	giv[110]|new[112]	_	_
16-9	2224-2236	endoperoxide	substance[110]|substance|object[112]	giv[110]|giv|new[112]	coref	20-7
16-10	2237-2241	ring	substance[110]|object[112]	giv[110]|new[112]	_	_
16-11	2242-2247	which	_	_	_	_
16-12	2248-2255	imparts	_	_	_	_
16-13	2256-2259	its	substance|abstract[114]	giv|new[114]	coref	21-11
16-14	2260-2273	anti-malarial	abstract[114]	new[114]	_	_
16-15	2274-2284	properties	abstract[114]	new[114]	_	_
16-16	2285-2286	(	_	_	_	_

#Text=Figure 6
17-1	2287-2293	Figure	object[115]	new[115]	coref	26-1[162_115]
17-2	2294-2295	6	object[115]	new[115]	_	_

#Text=) .
18-1	2296-2297	)	_	_	_	_
18-2	2298-2299	.	_	_	_	_

#Text=The mechanism of action is still unclear , and several possibilities have been proposed .
19-1	2300-2303	The	abstract[116]	new[116]	_	_
19-2	2304-2313	mechanism	abstract[116]	new[116]	_	_
19-3	2314-2316	of	abstract[116]	new[116]	_	_
19-4	2317-2323	action	abstract[116]|abstract	new[116]|new	_	_
19-5	2324-2326	is	_	_	_	_
19-6	2327-2332	still	_	_	_	_
19-7	2333-2340	unclear	_	_	_	_
19-8	2341-2342	,	_	_	_	_
19-9	2343-2346	and	_	_	_	_
19-10	2347-2354	several	abstract[118]	new[118]	_	_
19-11	2355-2368	possibilities	abstract[118]	new[118]	_	_
19-12	2369-2373	have	_	_	_	_
19-13	2374-2378	been	_	_	_	_
19-14	2379-2387	proposed	_	_	_	_
19-15	2388-2389	.	_	_	_	_

#Text=Most involve the degradation of the endoperoxide bridge in a heme-dependent process to form carbon centered radicals which then alkylate multiple targets including heme and proteins .
20-1	2390-2394	Most	_	_	_	_
20-2	2395-2402	involve	abstract|abstract	new|new	coref|none|none|none	21-1[128_0]|20-2[0_128]|20-2[0_205]|22-13
20-3	2403-2406	the	abstract[119]	new[119]	_	_
20-4	2407-2418	degradation	abstract[119]	new[119]	_	_
20-5	2419-2421	of	abstract[119]	new[119]	_	_
20-6	2422-2425	the	abstract[119]|object[121]	new[119]|new[121]	_	_
20-7	2426-2438	endoperoxide	abstract[119]|substance|object[121]	new[119]|giv|new[121]	coref	31-14
20-8	2439-2445	bridge	abstract[119]|object[121]	new[119]|new[121]	_	_
20-9	2446-2448	in	_	_	_	_
20-10	2449-2450	a	event[122]	new[122]	coref	32-6[204_122]
20-11	2451-2465	heme-dependent	event[122]	new[122]	_	_
20-12	2466-2473	process	event[122]	new[122]	_	_
20-13	2474-2476	to	_	_	_	_
20-14	2477-2481	form	event	new	coref	31-9[200_0]
20-15	2482-2488	carbon	substance	giv	_	_
20-16	2489-2497	centered	_	_	_	_
20-17	2498-2506	radicals	substance	new	_	_
20-18	2507-2512	which	_	_	_	_
20-19	2513-2517	then	_	_	_	_
20-20	2518-2526	alkylate	abstract[125]	new[125]	_	_
20-21	2527-2535	multiple	abstract[125]	new[125]	_	_
20-22	2536-2543	targets	abstract[125]	new[125]	_	_
20-23	2544-2553	including	abstract[125]	new[125]	_	_
20-24	2554-2558	heme	abstract[125]|substance	new[125]|new	coref	21-4
20-25	2559-2562	and	abstract[125]	new[125]	_	_
20-26	2563-2571	proteins	abstract[125]|substance	new[125]|new	_	_
20-27	2572-2573	.	_	_	_	_

#Text=The involvement of heme is consistent with the specificity of artemisinin towards Plasmodium spp . .
21-1	2574-2577	The	abstract[128]	new[128]	_	_
21-2	2578-2589	involvement	abstract[128]	new[128]	_	_
21-3	2590-2592	of	abstract[128]	new[128]	_	_
21-4	2593-2597	heme	abstract[128]|substance	new[128]|giv	coref	22-19[138_0]
21-5	2598-2600	is	_	_	_	_
21-6	2601-2611	consistent	_	_	_	_
21-7	2612-2616	with	_	_	_	_
21-8	2617-2620	the	abstract[130]	new[130]	_	_
21-9	2621-2632	specificity	abstract[130]	new[130]	_	_
21-10	2633-2635	of	abstract[130]	new[130]	_	_
21-11	2636-2647	artemisinin	abstract[130]|person	new[130]|giv	coref	23-5
21-12	2648-2655	towards	abstract[130]	new[130]	_	_
21-13	2656-2666	Plasmodium	abstract[130]|substance	new[130]|giv	_	_
21-14	2667-2670	spp	abstract[130]	new[130]	_	_
21-15	2671-2672	.	_	_	_	_
21-16	2673-2674	.	_	_	_	_

#Text=The direct cause of toxicity to the parasite is unclear but may involve interference with the conversion of heme to hemozoin , although this hypothesis has been disputed ( and reviewed in reference ) .
22-1	2675-2678	The	abstract[133]	new[133]	_	_
22-2	2679-2685	direct	abstract[133]	new[133]	_	_
22-3	2686-2691	cause	abstract[133]	new[133]	_	_
22-4	2692-2694	of	abstract[133]	new[133]	_	_
22-5	2695-2703	toxicity	abstract[133]|abstract[134]	new[133]|new[134]	_	_
22-6	2704-2706	to	abstract[133]|abstract[134]	new[133]|new[134]	_	_
22-7	2707-2710	the	abstract[133]|abstract[134]|person[135]	new[133]|new[134]|giv[135]	_	_
22-8	2711-2719	parasite	abstract[133]|abstract[134]|person[135]	new[133]|new[134]|giv[135]	_	_
22-9	2720-2722	is	_	_	_	_
22-10	2723-2730	unclear	_	_	_	_
22-11	2731-2734	but	_	_	_	_
22-12	2735-2738	may	_	_	_	_
22-13	2739-2746	involve	abstract	new	none	31-8
22-14	2747-2759	interference	abstract[136]	new[136]	_	_
22-15	2760-2764	with	abstract[136]	new[136]	_	_
22-16	2765-2768	the	abstract[136]|abstract[137]	new[136]|new[137]	_	_
22-17	2769-2779	conversion	abstract[136]|abstract[137]	new[136]|new[137]	_	_
22-18	2780-2782	of	abstract[136]|abstract[137]	new[136]|new[137]	_	_
22-19	2783-2787	heme	abstract[136]|abstract[137]|substance[138]	new[136]|new[137]|giv[138]	_	_
22-20	2788-2790	to	abstract[136]|abstract[137]|substance[138]	new[136]|new[137]|giv[138]	_	_
22-21	2791-2799	hemozoin	abstract[136]|abstract[137]|substance[138]|substance	new[136]|new[137]|giv[138]|new	_	_
22-22	2800-2801	,	_	_	_	_
22-23	2802-2810	although	_	_	_	_
22-24	2811-2815	this	abstract[140]	new[140]	_	_
22-25	2816-2826	hypothesis	abstract[140]	new[140]	_	_
22-26	2827-2830	has	_	_	_	_
22-27	2831-2835	been	_	_	_	_
22-28	2836-2844	disputed	_	_	_	_
22-29	2845-2846	(	_	_	_	_
22-30	2847-2850	and	_	_	_	_
22-31	2851-2859	reviewed	_	_	_	_
22-32	2860-2862	in	_	_	_	_
22-33	2863-2872	reference	abstract	new	_	_
22-34	2873-2874	)	_	_	_	_
22-35	2875-2876	.	_	_	_	_

#Text=The early stages of artemisinin biosynthesis in glandular trichomes of A. annua are now understood at the biochemical and molecular levels , although the exact mechanism of the later stages remains unclear .
23-1	2877-2880	The	abstract[142]	new[142]	_	_
23-2	2881-2886	early	abstract[142]	new[142]	_	_
23-3	2887-2893	stages	abstract[142]	new[142]	_	_
23-4	2894-2896	of	abstract[142]	new[142]	_	_
23-5	2897-2908	artemisinin	abstract[142]|person|abstract[144]	new[142]|giv|new[144]	coref	24-16
23-6	2909-2921	biosynthesis	abstract[142]|abstract[144]	new[142]|new[144]	_	_
23-7	2922-2924	in	abstract[142]|abstract[144]	new[142]|new[144]	_	_
23-8	2925-2934	glandular	abstract[142]|abstract[144]|plant[145]	new[142]|new[144]|new[145]	_	_
23-9	2935-2944	trichomes	abstract[142]|abstract[144]|plant[145]	new[142]|new[144]|new[145]	_	_
23-10	2945-2947	of	abstract[142]|abstract[144]|plant[145]	new[142]|new[144]|new[145]	_	_
23-11	2948-2950	A.	abstract[142]|abstract[144]|plant[145]|person	new[142]|new[144]|new[145]|new	_	_
23-12	2951-2956	annua	abstract[142]|abstract[144]|plant[145]	new[142]|new[144]|new[145]	_	_
23-13	2957-2960	are	_	_	_	_
23-14	2961-2964	now	_	_	_	_
23-15	2965-2975	understood	_	_	_	_
23-16	2976-2978	at	_	_	_	_
23-17	2979-2982	the	abstract[147]	new[147]	_	_
23-18	2983-2994	biochemical	abstract[147]	new[147]	_	_
23-19	2995-2998	and	abstract[147]	new[147]	_	_
23-20	2999-3008	molecular	abstract[147]	new[147]	_	_
23-21	3009-3015	levels	abstract[147]	new[147]	_	_
23-22	3016-3017	,	_	_	_	_
23-23	3018-3026	although	_	_	_	_
23-24	3027-3030	the	abstract[148]	new[148]	_	_
23-25	3031-3036	exact	abstract[148]	new[148]	_	_
23-26	3037-3046	mechanism	abstract[148]	new[148]	_	_
23-27	3047-3049	of	abstract[148]	new[148]	_	_
23-28	3050-3053	the	abstract[148]|abstract[149]	new[148]|giv[149]	_	_
23-29	3054-3059	later	abstract[148]|abstract[149]	new[148]|giv[149]	_	_
23-30	3060-3066	stages	abstract[148]|abstract[149]	new[148]|giv[149]	_	_
23-31	3067-3074	remains	_	_	_	_
23-32	3075-3082	unclear	_	_	_	_
23-33	3083-3084	.	_	_	_	_

#Text=Current efforts now focus on the regulation of this pathway in an effort to improve artemisinin production directly in plants .
24-1	3085-3092	Current	abstract[150]	new[150]	_	_
24-2	3093-3100	efforts	abstract[150]	new[150]	_	_
24-3	3101-3104	now	_	_	_	_
24-4	3105-3110	focus	_	_	_	_
24-5	3111-3113	on	_	_	_	_
24-6	3114-3117	the	abstract[151]	new[151]	_	_
24-7	3118-3128	regulation	abstract[151]	new[151]	_	_
24-8	3129-3131	of	abstract[151]	new[151]	_	_
24-9	3132-3136	this	abstract[151]|abstract[152]	new[151]|new[152]	coref	25-1[157_152]
24-10	3137-3144	pathway	abstract[151]|abstract[152]	new[151]|new[152]	_	_
24-11	3145-3147	in	_	_	_	_
24-12	3148-3150	an	abstract[153]	new[153]	_	_
24-13	3151-3157	effort	abstract[153]	new[153]	_	_
24-14	3158-3160	to	_	_	_	_
24-15	3161-3168	improve	_	_	_	_
24-16	3169-3180	artemisinin	person|abstract[155]	giv|new[155]	_	_
24-17	3181-3191	production	abstract[155]	new[155]	_	_
24-18	3192-3200	directly	_	_	_	_
24-19	3201-3203	in	_	_	_	_
24-20	3204-3210	plants	plant	giv	_	_
24-21	3211-3212	.	_	_	_	_

#Text=The pathway begins with the conversion of FDP to amorpha-4,11-diene by amorpha-4,11-diene synthase (
25-1	3213-3216	The	abstract[157]	giv[157]	_	_
25-2	3217-3224	pathway	abstract[157]	giv[157]	_	_
25-3	3225-3231	begins	_	_	_	_
25-4	3232-3236	with	_	_	_	_
25-5	3237-3240	the	event[158]	new[158]	_	_
25-6	3241-3251	conversion	event[158]	new[158]	_	_
25-7	3252-3254	of	event[158]	new[158]	_	_
25-8	3255-3258	FDP	event[158]|substance	new[158]|giv	_	_
25-9	3259-3261	to	_	_	_	_
25-10	3262-3280	amorpha-4,11-diene	substance	new	coref	29-11[180_0]
25-11	3281-3283	by	_	_	_	_
25-12	3284-3302	amorpha-4,11-diene	abstract[161]	new[161]	_	_
25-13	3303-3311	synthase	abstract[161]	new[161]	_	_
25-14	3312-3313	(	_	_	_	_

#Text=Figure 6
26-1	3314-3320	Figure	object[162]	giv[162]	_	_
26-2	3321-3322	6	object[162]	giv[162]	_	_

#Text=) .
27-1	3323-3324	)	_	_	_	_
27-2	3325-3326	.	_	_	_	_

#Text=Biochemical characterization and metabolite profiling of plant tissue indicated the presence of this olefin as well as its oxygenated derivatives artemisinic alcohol and aldehyde , dihydroartemisinic alcohol and aldehyde , and dihydroartemisinic acid .
28-1	3327-3338	Biochemical	substance|abstract[164]	new|new[164]	_	_
28-2	3339-3355	characterization	abstract[164]	new[164]	_	_
28-3	3356-3359	and	_	_	_	_
28-4	3360-3370	metabolite	object[165]	new[165]	_	_
28-5	3371-3380	profiling	object[165]	new[165]	_	_
28-6	3381-3383	of	object[165]	new[165]	_	_
28-7	3384-3389	plant	object[165]|plant|object[167]	new[165]|giv|new[167]	_	_
28-8	3390-3396	tissue	object[165]|object[167]	new[165]|new[167]	_	_
28-9	3397-3406	indicated	_	_	_	_
28-10	3407-3410	the	abstract[168]	new[168]	_	_
28-11	3411-3419	presence	abstract[168]	new[168]	_	_
28-12	3420-3422	of	abstract[168]	new[168]	_	_
28-13	3423-3427	this	abstract[168]|substance[169]	new[168]|new[169]	ana	28-18[0_169]
28-14	3428-3434	olefin	abstract[168]|substance[169]	new[168]|new[169]	_	_
28-15	3435-3437	as	_	_	_	_
28-16	3438-3442	well	_	_	_	_
28-17	3443-3445	as	_	_	_	_
28-18	3446-3449	its	substance|substance[171]	giv|new[171]	_	_
28-19	3450-3460	oxygenated	substance[171]	new[171]	_	_
28-20	3461-3472	derivatives	substance[171]	new[171]	_	_
28-21	3473-3484	artemisinic	substance[172]	new[172]	_	_
28-22	3485-3492	alcohol	substance[172]	new[172]	_	_
28-23	3493-3496	and	_	_	_	_
28-24	3497-3505	aldehyde	substance	new	_	_
28-25	3506-3507	,	_	_	_	_
28-26	3508-3526	dihydroartemisinic	substance[174]	new[174]	coref	29-13[182_174]
28-27	3527-3534	alcohol	substance[174]	new[174]	_	_
28-28	3535-3538	and	_	_	_	_
28-29	3539-3547	aldehyde	substance	new	coref	29-16
28-30	3548-3549	,	_	_	_	_
28-31	3550-3553	and	_	_	_	_
28-32	3554-3572	dihydroartemisinic	substance[176]	new[176]	coref	30-7[193_176]
28-33	3573-3577	acid	substance[176]	new[176]	_	_
28-34	3578-3579	.	_	_	_	_

#Text=Following the cloning and expression of CYP71AV1 , which converts amorpha-4,11-diene to artemisinic alcohol and aldehyde , Zhang et al. characterized the artemisinic aldehyde Δ11(13 ) reductase ( Double bond reductase 2 , Dbr2 ) , which preferentially reduces artemisinic aldehyde to dihydroartemisinic aldehyde .
29-1	3580-3589	Following	_	_	_	_
29-2	3590-3593	the	abstract[177]	new[177]	_	_
29-3	3594-3601	cloning	abstract[177]	new[177]	_	_
29-4	3602-3605	and	_	_	_	_
29-5	3606-3616	expression	abstract[178]	new[178]	_	_
29-6	3617-3619	of	abstract[178]	new[178]	_	_
29-7	3620-3628	CYP71AV1	abstract[178]|abstract	new[178]|new	_	_
29-8	3629-3630	,	_	_	_	_
29-9	3631-3636	which	_	_	_	_
29-10	3637-3645	converts	_	_	_	_
29-11	3646-3664	amorpha-4,11-diene	substance[180]	giv[180]	_	_
29-12	3665-3667	to	substance[180]	giv[180]	_	_
29-13	3668-3679	artemisinic	substance[180]|substance|substance[182]	giv[180]|new|giv[182]	coref	29-23
29-14	3680-3687	alcohol	substance[180]|substance[182]	giv[180]|giv[182]	_	_
29-15	3688-3691	and	substance[180]	giv[180]	_	_
29-16	3692-3700	aldehyde	substance[180]|substance	giv[180]|giv	coref	29-22[186_0]
29-17	3701-3702	,	substance[180]	giv[180]	_	_
29-18	3703-3708	Zhang	substance[180]|person	giv[180]|new	_	_
29-19	3709-3711	et	substance[180]	giv[180]	_	_
29-20	3712-3715	al.	substance[180]	giv[180]	_	_
29-21	3716-3729	characterized	_	_	_	_
29-22	3730-3733	the	substance[186]	giv[186]	coref	29-40[190_186]
29-23	3734-3745	artemisinic	place|substance[186]	giv|giv[186]	_	_
29-24	3746-3754	aldehyde	substance[186]	giv[186]	_	_
29-25	3755-3761	Δ11(13	substance[186]	giv[186]	_	_
29-26	3762-3763	)	_	_	_	_
29-27	3764-3773	reductase	abstract	new	appos	29-29[189_0]
29-28	3774-3775	(	_	_	_	_
29-29	3776-3782	Double	abstract[189]	giv[189]	_	_
29-30	3783-3787	bond	abstract|abstract[189]	new|giv[189]	_	_
29-31	3788-3797	reductase	abstract[189]	giv[189]	_	_
29-32	3798-3799	2	abstract[189]	giv[189]	_	_
29-33	3800-3801	,	abstract[189]	giv[189]	_	_
29-34	3802-3806	Dbr2	abstract[189]	giv[189]	_	_
29-35	3807-3808	)	_	_	_	_
29-36	3809-3810	,	_	_	_	_
29-37	3811-3816	which	_	_	_	_
29-38	3817-3831	preferentially	_	_	_	_
29-39	3832-3839	reduces	_	_	_	_
29-40	3840-3851	artemisinic	substance[190]	giv[190]	coref	29-43[191_190]
29-41	3852-3860	aldehyde	substance[190]	giv[190]	_	_
29-42	3861-3863	to	_	_	_	_
29-43	3864-3882	dihydroartemisinic	substance[191]	giv[191]	coref	30-10[0_191]
29-44	3883-3891	aldehyde	substance[191]	giv[191]	_	_
29-45	3892-3893	.	_	_	_	_

#Text=This substrate is then converted to dihydroartemisinic acid by aldehyde dehydrogenase 1 ( Aldh1 ) .
30-1	3894-3898	This	object[192]	new[192]	_	_
30-2	3899-3908	substrate	object[192]	new[192]	_	_
30-3	3909-3911	is	_	_	_	_
30-4	3912-3916	then	_	_	_	_
30-5	3917-3926	converted	_	_	_	_
30-6	3927-3929	to	_	_	_	_
30-7	3930-3948	dihydroartemisinic	substance[193]	giv[193]	coref	31-2[198_193]
30-8	3949-3953	acid	substance[193]	giv[193]	_	_
30-9	3954-3956	by	_	_	_	_
30-10	3957-3965	aldehyde	substance|time[196]	giv|new[196]	_	_
30-11	3966-3979	dehydrogenase	time|time[196]	new|new[196]	_	_
30-12	3980-3981	1	time[196]	new[196]	_	_
30-13	3982-3983	(	time[196]	new[196]	_	_
30-14	3984-3989	Aldh1	time[196]|time	new[196]|new	_	_
30-15	3990-3991	)	time[196]	new[196]	_	_
30-16	3992-3993	.	_	_	_	_

#Text=From dihydroartemisinic acid , the remaining steps involve the photooxidative formation of the endoperoxide ring .
31-1	3994-3998	From	_	_	_	_
31-2	3999-4017	dihydroartemisinic	substance[198]	giv[198]	_	_
31-3	4018-4022	acid	substance[198]	giv[198]	_	_
31-4	4023-4024	,	_	_	_	_
31-5	4025-4028	the	event[199]	new[199]	_	_
31-6	4029-4038	remaining	event[199]	new[199]	_	_
31-7	4039-4044	steps	event[199]	new[199]	_	_
31-8	4045-4052	involve	abstract	new	coref	32-11[205_0]
31-9	4053-4056	the	event[200]	new[200]	_	_
31-10	4057-4071	photooxidative	event[200]	new[200]	_	_
31-11	4072-4081	formation	event[200]	new[200]	_	_
31-12	4082-4084	of	event[200]	new[200]	_	_
31-13	4085-4088	the	event[200]|object[202]	new[200]|giv[202]	_	_
31-14	4089-4101	endoperoxide	event[200]|substance|object[202]	new[200]|giv|giv[202]	_	_
31-15	4102-4106	ring	event[200]|object[202]	new[200]|giv[202]	_	_
31-16	4107-4108	.	_	_	_	_

#Text=However , the details of this process , such as the potential involvement of additional enzyme activities , are currently unclear .
32-1	4109-4116	However	_	_	_	_
32-2	4117-4118	,	_	_	_	_
32-3	4119-4122	the	abstract[203]	new[203]	_	_
32-4	4123-4130	details	abstract[203]	new[203]	_	_
32-5	4131-4133	of	abstract[203]	new[203]	_	_
32-6	4134-4138	this	abstract[203]|event[204]	new[203]|giv[204]	_	_
32-7	4139-4146	process	abstract[203]|event[204]	new[203]|giv[204]	_	_
32-8	4147-4148	,	abstract[203]	new[203]	_	_
32-9	4149-4153	such	abstract[203]	new[203]	_	_
32-10	4154-4156	as	abstract[203]	new[203]	_	_
32-11	4157-4160	the	abstract[203]|abstract[205]	new[203]|new[205]	_	_
32-12	4161-4170	potential	abstract[203]|abstract[205]	new[203]|new[205]	_	_
32-13	4171-4182	involvement	abstract[203]|abstract[205]	new[203]|new[205]	_	_
32-14	4183-4185	of	abstract[203]|abstract[205]	new[203]|new[205]	_	_
32-15	4186-4196	additional	abstract[203]|abstract[205]|abstract[207]	new[203]|new[205]|new[207]	_	_
32-16	4197-4203	enzyme	abstract[203]|abstract[205]|substance|abstract[207]	new[203]|new[205]|new|new[207]	_	_
32-17	4204-4214	activities	abstract[203]|abstract[205]|abstract[207]	new[203]|new[205]|new[207]	_	_
32-18	4215-4216	,	_	_	_	_
32-19	4217-4220	are	_	_	_	_
32-20	4221-4230	currently	_	_	_	_
32-21	4231-4238	unclear	_	_	_	_
32-22	4239-4240	.	_	_	_	_
